2006D-0044:
Guidance for Industry on Patient-Reported Outcome Measures: Use
in Medical Product Development to Support Labeling Claims
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
| GDL1
|
| 02/02/2006
|
| 02/15/2006
|
| Federal Government
|
| GUIDANCE
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| GUIDANCE
|
|
|
| NAD1
|
|
|
| 02/02/2006
|
| FDA
|
| FDA
|
| 02/03/2006
|
| 5862-5863
|
| 04/04/2006
|
| txt
|
|
|
|
| Signature:
|
| SHUREN, JEFFREY
|
|
|
| C1
|
| 02/22/2006
|
| 02/21/2006
|
| Academia
|
| Institute of Health
Economics
|
|
|
|
|
|
|
| pdf
Attachments
|
|
|
|
| Signature:
|
| David Feeny, PhD et al.
|
|
|
| C2
|
| 04/04/2006
|
| 04/04/2006
|
| Device Association
|
| Advanced Medical Technology
Association (AdvaMed)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Tara Federici
|
|
|
| C3
|
| 04/04/2006
|
| 04/04/2006
|
| Private Industry
|
| etrials, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Richard Piazza, PharmD
|
|
|
| C4
|
| 04/04/2006
|
| 04/03/2006
|
| Private Industry
|
| UCB, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Robert A. Paarlberg
|
|
|
| C5
|
| 04/04/2006
|
| 04/03/2006
|
| Device Association
|
| Healthcare Technology
Systems
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Robert A. Paarlberg
|
|
|
| C6
|
| 04/04/2006
|
| 04/03/2006
|
| Drug Industry
|
| Genentech
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Robert L. Garnick, PhD
|
|
|
| EC1
|
| 04/07/2006
|
| 02/27/2006
|
| Health Professional
|
| M. D. Anderson Cancer
Center
|
|
|
|
|
|
|
| htm
|
|
|
|
| Signature:
|
| Meyers, Christina
|
|
|
| EC2
|
| 04/07/2006
|
| 03/15/2006
|
| Academia
|
| EMGO Institute, VU
University Medical Center
|
|
|
|
|
|
|
| DOC
|
|
|
|
| Signature:
|
| Terwee, Caroline
|
|
|
| EC3
|
| 04/07/2006
|
| 03/17/2006
|
| Federal Government
|
| NIH
|
|
|
|
|
|
|
| htm
|
|
|
|
|
|
| Signature:
|
| Riley, William
|
|
|
|
| EC4
|
| 04/07/2006
|
| 03/28/2006
|
| Health Professional
|
| Capitol Outcomes Research,
Inc.
|
|
|
|
|
|
|
| htm
|
|
|
|
| Signature:
|
| Meyerhoff, Allen
|
|
|
| EC5
|
| 04/07/2006
|
| 03/30/2006
|
| International Organization
|
| EORTC Data Center
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Bottomley, Andrew
|
|
|
|
| EC6
|
| 04/07/2006
|
| 03/31/2006
|
| Drug Industry
|
| Eli Lilly and Company
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Melfi, Catherine
|
|
|
| EC7
|
| 04/07/2006
|
| 03/31/2006
|
| Academia
|
| Stanford University
|
|
|
|
|
|
|
|
|
|
|
|
| Signature:
|
| Fries, James
|
|
|
| EC8
|
| 04/07/2006
|
| 04/03/2006
|
| Drug Industry
|
| GlaxoSmithKline
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Stokley, M.S.P.H., Anne N.
|
|
|
| C7
|
| 04/10/2006
|
| 03/31/2006
|
| Academia
|
| Stanford University
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Dr. James Fries
|
|
|
| C8
|
| 04/10/2006
|
| 03/30/2006
|
| Drug Industry
|
| AstraZeneca Pharmaceuticals,
LP
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Debra N. Shiozawa, PhD
|
|
|
| EMC1
|
| 03/31/2006
|
| 03/31/2006
|
| Drug Industry
|
| Abbott Laboratories
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Douglas R Sporn
| |
|
|
|
Top | Up
| Next | Most Recent Page last updated:
January 8, 2007
|